Sio Capital Management »

Pacira Pharmaceuticals shares owned by Sio Capital Management

Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by Sio Capital Management from 13F filings

Historical chart of Sio Capital Management investment in Pacira Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pacira Pharmaceuticals held by Sio Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pacira Pharmaceuticals by Sio Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $13M 456k 28.61
2024-03-31 $3.3M 112k 29.22
2018-09-30 $14M 281k 49.15

More positions owned by Sio Capital Management

Insmed Com Par $.01 Put Option (INSM)
Labcorp Holdings Com Shs (LH)
Teleflex Incorporated (TFX)
Zimmer Holdings (ZBH)
Smith & Nephew Spdn Adr New (SNN)
Pacira Pharmaceuticals Put Option (PCRX)
Organon & Co Common Stock (OGN)
GSK Sponsored Adr (GSK)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Vaxart Com New (VXRT)
Tyra Biosciences (TYRA)
Abbott Laboratories (ABT)
Cigna Corp (CI)
Kenvue (KVUE)
Disc Medicine (IRON)

View all positions for Sio Capital Management

Top funds holding Pacira Pharmaceuticals

BlackRock
Vanguard Group
Renaissance Technologies
State Street Corporation
Frontier Capital Management
Dimensional Fund Advisors
Pacer Advisors
Macquarie Group
Stephens Investment Management Group
Geode Capital Management
Doma Perpetual Capital Management
Rice Hall James & Associates
Marshall Wace
Baillie Gifford & Co
Rock Springs Capital Management

View all funds holding Pacira Pharmaceuticals